Metagenics, Inc.
Records under this name other than the patents Metagenics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,139 | Protein Kinase Modulation by Hops and Acacia Products Term ended Ended no later than Aug 9, 2026 · Medium confidence | Term ended | Ended no later than Aug 9, 2026 | Medium confidence |
| US 8,092,846 | Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines Term ended Term ended Mar 19, 2026 · High confidence | Term ended | Term ended Mar 19, 2026 | High confidence |
| US 8,193,201 | Synergistic Anti-Inflammatory Pharmaceutical Compositions and Related Methods Using Curcuminoids or Methylxanthines Term ended Term ended Feb 27, 2024 · High confidence | Term ended | Term ended Feb 27, 2024 | High confidence |
| US 7,279,185 | Curcuminoid Compositions Exhibiting Synergistic Inhibition of the Expression And/Or Activity of CYCLOOXYGENASE-2 Term ended Term ended Dec 22, 2023 · High confidence | Term ended | Term ended Dec 22, 2023 | High confidence |
| US 6,432,453 | Dietary Supplement Containing Glycerol Ester of Conjugated Linoleic Acid and Rosemary Extract Containing Carnosic Acid Term ended Term ended Feb 1, 2021 · High confidence | Term ended | Term ended Feb 1, 2021 | High confidence |
| US 6,447,809 | Composition for promoting healthy bone structure Formerly held Term ended Term ended May 11, 2020 · USPTO record | Term ended | Term ended May 11, 2020 | USPTO record |
| US 7,029,703 | Composition for Promoting Healthy Bone Structure Term ended Ended no later than May 11, 2020 · Low confidence | Term ended | Ended no later than May 11, 2020 | Low confidence |
| US 6,534,086 | Composition and method for treatment of inflammation and pain in mammals Term ended Term ended Mar 6, 2020 · USPTO record | Term ended | Term ended Mar 6, 2020 | USPTO record |
| US 6,949,260 | Method for Treatment of Inflammation and Pain in Mammals Term ended Term ended Mar 6, 2020 · Medium confidence | Term ended | Term ended Mar 6, 2020 | Medium confidence |
| US 6,241,983 | Bacteria-and fiber-containing composition for human gastrointestinal health Term ended Term ended May 26, 2019 · USPTO record | Term ended | Term ended May 26, 2019 | USPTO record |